NDC properties for "Retacrit" (RxCUI 2047623)
About this data
The tables show NDC propoerties for Retacrit with the RxCUI 2047623
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Retacrit (RxCUI 2047623)
| BLA | BLA125545 |
|---|---|
| MMSL_CODE | BD33289 |
| RxCUI | 2047623 |
| SPL_SET_ID | 3af26b0d-8ad0-44e1-a538-8bdb5ab39374 |
| Prescribable Synonym | Retacrit 40,000 UNT in 1 ML Injection |
| RXNAV_STR | 1 ML Retacrit 40000 UNT/ML Injection |
| RxNorm Name | 1 ML epoetin alfa-epbx 40000 UNT/ML Injection [Retacrit] |
| RxNorm Synonym | 1 ML EPO-epbx 40000 UNT/ML Injection [Retacrit] |
| RxNorm Synonym | 1 ML ERYTHROPOIETIN-epbx 40000 UNT/ML Injection [Retacrit] |
| RxNorm Synonym | 1 ML Retacrit 40000 UNT/ML Injection |
| RxNorm Synonym | Retacrit 40,000 UNT per 1 ML Injection |
| Related queries | Interactions (for RxCUI 2047623) |
NDC Properties
NDC Item 00069130901
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-01 |
| NDC Item | 00069130901 |
| Packaging | 1 mL in 1 VIAL, SINGLE-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |
NDC Item 00069130904
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-04 |
| NDC Item | 00069130904 |
| Packaging | 4 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |
NDC Item 00069130910
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-10 |
| NDC Item | 00069130910 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |
NDC Item 00069130901
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-01 |
| NDC Item | 00069130901 |
| Packaging | 1 mL in 1 VIAL, SINGLE-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |
NDC Item 00069130904
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-04 |
| NDC Item | 00069130904 |
| Packaging | 4 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |
NDC Item 00069130910
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-10 |
| NDC Item | 00069130910 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |
NDC Item 00069130901
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-01 |
| NDC Item | 00069130901 |
| Packaging | 1 mL in 1 VIAL, SINGLE-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |
NDC Item 00069130904
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-04 |
| NDC Item | 00069130904 |
| Packaging | 4 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |
NDC Item 00069130910
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-10 |
| NDC Item | 00069130910 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1309 |